Italy Welcomes All AstraZeneca Vaccine Versions
Italian authorities announced on September 23, 2021, all versions of the AstraZeneca vaccine are considered equivalent to the other vaccines that have already been approved for use by the country’s authorities, SchengenVisaInfo.com reports.
The Vaxzevria - AstraZeneca COVID-19 vaccine is made from ChAdOx1, a weakened version of a common cold virus (adenovirus).
There are three sub-versions of the AstraZeneca vaccine:
- Covishield (Serum Institute of India)
- R-CoVI (R-Pharm)
- Covid-19 vaccine-recombinant (Fiocruz)
“The certificates issued by health authorities in Canada, Japan, Israel, the United Kingdom and the United States of America, as well as those issued by foreign health authorities following vaccination with EMA-authorised vaccines or with Covishield (Serum Institute of India), R-CoVI (R-Pharm), and Covid-19vaccine-recombinant (Fiocruz) vaccines, are recognized as equivalent to national and EU digital green certificates,” the statement of the Ministry of Foreign Affairs and International Cooperation reads.
The Italian Green Pass is an extension of the EU Digital COVID-19 Certificate, meaning that Italy recognizes all other equivalents that other countries have issued, regardless if they are part of the European Union or not.